Related Experiment Video
Updated: Jun 26, 2025

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
Cell Cycle Checkpoints p16 and p21-Strong Predictors of Clinicopathologic Outcomes in High-Grade Osteosarcoma
Elham Nasri1, Dianne E Torrence, Terrie Vasilopoulos2
1From the Department of Pathology, Immunology, and Laboratory Medicine, University of Florida College of Medicine, Gainesville, FL.
High p16 expression predicts better outcomes in high-grade osteosarcoma. Moderate p21 expression is linked to improved survival, while extreme levels indicate higher metastasis risk. These markers aid in risk stratification.
Area of Science:
- Oncology
- Molecular Pathology
- Biomarker Research
Background:
- High-grade osteosarcoma is an aggressive bone cancer with variable patient outcomes.
- Accurate prognostic markers are crucial for effective treatment planning and risk stratification.
- Cell cycle regulators like p16 and p21 are potential biomarkers in various cancers.
Purpose of the Study:
- To evaluate the prognostic value of p16 and p21 expression in high-grade osteosarcoma.
- To assess the predictive capability of these markers, individually and in combination, for disease outcomes.
- To determine their utility in predicting response to chemotherapy and patient survival.
Main Methods:
- Immunohistochemistry was used to measure p16 and p21 expression in 101 high-grade osteosarcoma patients.
- Clinicopathologic data were collected and analyzed.
- Statistical methods assessed the correlation between marker expression and disease outcomes.
Main Results:
- High p16 expression (>90%) strongly predicted a good histologic response to chemotherapy, improved 5-year survival, and reduced metastasis risk.
- Moderate p21 expression (1-50%) was associated with better outcomes compared to low (<1%) or high (>50%) expression, which correlated with increased metastasis and decreased survival.
- Combined p16 and p21 expression showed a stronger predictive relationship to 5-year survival than p21 alone or tumor necrosis.
Conclusions:
- p16 and p21 expression levels are valuable prognostic indicators in high-grade osteosarcoma.
- These markers can aid in initial patient assessment and risk stratification for treatment.
- Further validation in larger cohorts is recommended for clinical trial application.
Related Concept Videos
Inhibition of Cdk Activity
DNA Damage can Stall the Cell Cycle
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Negative Regulator Molecules
Abnormal Proliferation

